| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michal Rivel, Anat Achiron, Yael Stern, Gabi Zeilig, Ruth Defri. Emotional burden among MS patients: associations between specific chronic pain diagnoses and psychological features. Journal of neurology. 2023-10-24. PMID:37875677. |
central neuropathic pain (cnp) and musculoskeletal pain (msp) are often comorbid with multiple sclerosis (ms), yet data on the emotional burden entailed by this comorbidity are very limited. |
2023-10-24 |
2023-11-08 |
human |
| Michal Rivel, Anat Achiron, Mark Dolev, Yael Stern, Gabi Zeilig, Ruth Defri. Unique features of central neuropathic pain in multiple sclerosis: Results of a cluster analysis. European journal of pain (London, England). 2022-03-09. PMID:35263811. |
central neuropathic pain (cnp) is an excruciating condition, prevalent in up to a third of patients with multiple sclerosis (ms). |
2022-03-09 |
2023-08-13 |
Not clear |
| Michal Rivel, Anat Achiron, Mark Dolev, Yael Stern, Gabi Zeilig, Ruth Defri. Central Neuropathic Pain in Multiple Sclerosis Is Associated with Impaired Innocuous Thermal Pathways and Neuronal Hyperexcitability. Pain medicine (Malden, Mass.). vol 22. issue 10. 2021-10-22. PMID:33734398. |
about one-third of patients with multiple sclerosis (ms) suffers from chronic and excruciating central neuropathic pain (cnp). |
2021-10-22 |
2023-08-13 |
Not clear |
| Jaskirat Kaur, Shampa Ghosh, Asish Kumar Sahani, Jitendra Kumar Sinh. Mental imagery training for treatment of central neuropathic pain: a narrative review. Acta neurologica Belgica. vol 119. issue 2. 2019-12-26. PMID:30989503. |
we were able to finalize twelve studies where mental imagery was used for treating cnp in spinal cord injury (sci), stroke and multiple sclerosis. |
2019-12-26 |
2023-08-13 |
Not clear |
| Amir Reza Heidari, Samaneh Boroumand-Noughabi, Reza Nosratabadi, Fahimeh Lavi Arab, Nafiseh Tabasi, Maryam Rastin, Mahmoud Mahmoud. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG Multiple sclerosis and related disorders. vol 29. 2019-07-16. PMID:30685444. |
acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of c57bl/6 mice model with mog the majority of patients with multiple sclerosis (ms) suffer from central neuropathic pain (cnp). |
2019-07-16 |
2023-08-13 |
mouse |
| Fabrizia Monteleone, Carolina G Nicoletti, Mario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, Roberto Furlan, Annamaria Finardi, Girolama A Marfia, Diego Centonze, Francesco Mor. Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain. Journal of neuroimmunology. vol 314. 2019-07-05. PMID:29174194. |
central neuropathic pain (cnp) is common and disabling among patients with multiple sclerosis (ms). |
2019-07-05 |
2023-08-13 |
Not clear |
| Darin T Okuda, Kara Melmed, Takashi Matsuwaki, Anders Blomqvist, Arthur D Bud Crai. Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions. Annals of clinical and translational neurology. vol 1. issue 8. 2014-10-30. PMID:25356427. |
to determine a neuro-anatomic cause for central neuropathic pain (cnp) observed in multiple sclerosis (ms) patients. |
2014-10-30 |
2023-08-13 |
Not clear |
| Keiko Iwata, Cecilia C Caf\\xc3\\xa9-Mendes, Andrea Schmitt, Johann Steiner, Takayuki Manabe, Hideo Matsuzaki, Peter Falkai, Christoph W Turck, Daniel Martins-de-Souz. The human oligodendrocyte proteome. Proteomics. vol 13. issue 23-24. 2014-08-05. PMID:24167090. |
ol-specific proteins, such as myelin basic protein (mbp) and 2',3'-cyclic nucleotide 3'-phosphodiesterase (cnp), as well as other proteins involved in multiple sclerosis and schizophrenia were also identified and are discussed. |
2014-08-05 |
2023-08-12 |
human |
| R M Langford, J Mares, A Novotna, M Vachova, I Novakova, W Notcutt, S Ratcliff. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. Journal of neurology. vol 260. issue 4. 2013-09-26. PMID:23180178. |
central neuropathic pain (cnp) occurs in many multiple sclerosis (ms) patients. |
2013-09-26 |
2023-08-12 |
Not clear |
| V Millet, M Marder, L A Pasquin. Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination. Experimental neurology. vol 233. issue 1. 2012-03-25. PMID:22155618. |
adult cnp::egfp mice could be considered a useful tool to evaluate future therapies for demyelinating diseases such as multiple sclerosis (ms), since these animals present chronic demyelination with axonal degeneration, a characteristic of such pathologies. |
2012-03-25 |
2023-08-12 |
mouse |
| S Rossi, G Mataluni, C Codec\\xc3\\xa0, S Fiore, F Buttari, A Musella, M Castelli, G Bernardi, D Centonz. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. European journal of neurology. vol 16. issue 3. 2009-07-09. PMID:19364364. |
central neuropathic pain (cnp) is a prevalent and distressing symptom in patients with multiple sclerosis (ms). |
2009-07-09 |
2023-08-12 |
Not clear |
| David J Rog, Turo J Nurmikko, Carolyn A Youn. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clinical therapeutics. vol 29. issue 9. 2008-01-08. PMID:18035205. |
central neuropathic pain (cnp), pain initiated or caused by a primary lesion or dysfunction of the central nervous system, occurs in ~28% of patients with multiple sclerosis (ms). |
2008-01-08 |
2023-08-12 |
Not clear |
| D Johnson, S Sato, R H Quarles, T Inuzuka, R O Brady, W W Tourtellott. Quantitation of the myelin-associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients. Journal of neurochemistry. vol 46. issue 4. 1986-04-16. PMID:2419505. |
the reduction of mag content in periplaque regions from all nine multiple sclerosis plaques examined was significantly greater than the reductions of bp level and cnp activity. |
1986-04-16 |
2023-08-11 |
human |
| D Johnson, S Sato, R H Quarles, T Inuzuka, R O Brady, W W Tourtellott. Quantitation of the myelin-associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients. Journal of neurochemistry. vol 46. issue 4. 1986-04-16. PMID:2419505. |
in a periplaque region and nawm from the most rapidly progressing case of multiple sclerosis examined, the mag content was between 30 and 35% of the control level, whereas bp and plp levels and cnp activity were between 50 and 85% of control values. |
1986-04-16 |
2023-08-11 |
human |
| S C Rastogi, J Clause. Membrane-bound 2',3',-cyclic nucleotide 3'-phosphohydrolase activity of lymphocytes, granulocytes and erythrocytes in multiple sclerosis. Acta neurologica Scandinavica. vol 71. issue 4. 1985-07-17. PMID:2988262. |
a sensitive fluorimetric method was used for the assay of 2',3'-cyclic nucleotide 3'-phosphohydrolase (cnp) activity of lymphocyte, granulocyte and erythrocyte membranes from patients with multiple sclerosis (ms). |
1985-07-17 |
2023-08-11 |
Not clear |
| J L Trotter, C L Wegescheide, W F Garve. Regional studies of myelin proteins in human brain and spinal cord. Neurochemical research. vol 9. issue 1. 1984-06-18. PMID:6201756. |
regions with special sensitivity to the multiple sclerosis process had relatively lower proportions of cnp in several, but not all cases. |
1984-06-18 |
2023-08-12 |
human |
| I Raes, S Weissbarth, H S Maker, G M Lehre. 2', 3'-cyclic nucleotide 3'-phosphodiesterase in cerebrospinal fluid. Neurology. vol 31. issue 10. 1982-10-21. PMID:6287355. |
patients with radicular syndromes had slightly higher than average cnp activities, but there was no difference in enzyme activities of 47 patients with multiple sclerosis and the general neurologic population. |
1982-10-21 |
2023-08-12 |
Not clear |
| K Eickhoff, R Heipert. The activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase in human cerebrospinal fluid. Clinica chimica acta; international journal of clinical chemistry. vol 92. issue 2. 1979-12-29. PMID:487580. |
comparing csf from patients with multiple sclerosis to control csf no significant difference is found, although a small proportion of ms patients has an elevated has an elevated cnp activity in their csf. |
1979-12-29 |
2023-08-11 |
human |
| N L Banik, L B Mauldin, E L Hoga. Activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase in human cerebrospinal fluid. Annals of neurology. vol 5. issue 6. 1979-10-24. PMID:224801. |
activity of the myelin marker enzyme 2',3'-cyclic nucleotide 3'-phosphohydrolase (cnp) was assayed in cerebrospinal fluid samples obtained from patients with multiple sclerosis (ms) and other neurological diseases. |
1979-10-24 |
2023-08-11 |
human |